Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP


 

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by signing an agreement to acquire CRYOPDP, a leading global provider of innovative temperature-controlled logistics solutions to the clinical research, pharmaceutical and cell and gene therapy markets, headquartered in Paris, France. The agreement provides for Cryoport to acquire CRYOPDP in an all cash transaction valued at approximately €49 million. CRYOPDP generated over €42 million of revenue in 2019 and is expected to be immediately accretive to Cryoport's earnings upon closing. The acquisition is expected to close within 60 days, subject to customary closing conditions.

CRYOPDP has over 220 dedicated employees located in 22 global facilities in 12 countries and has more than 25 years of experience serving the life sciences and healthcare industries, providing customized and turnkey transport solutions, with over 300,000 high-value, time critical annual shipments globally. CRYOPDP covers a significant portion of the healthcare temperature-controlled supply chain including packaging, pick-pack kit preparation, premium services and specialty courier support.

Upon completion of the acquisition, CRYOPDP will provide significant complementary synergies with Cryoport's operating entity, Cryoport Systems, with very limited overlap in capabilities and infrastructure, from a geographic as well as service and product support standpoint. As a Cryoport company, CRYOPDP will strengthen Cryoport's geographic footprint and infrastructure within Europe, the Middle East and Africa ("EMEA") and the Asia Pacific ("APAC") regions, all of which are emerging high growth areas in the biopharma and the cell and gene therapy market.

Working closely with Cryoport Systems, CRYOPDP will support the life sciences supply chain across the full spectrum of controlled temperature ranges and create significant global cross-selling opportunities. As a unified platform, the parties believe that both Cryoport Systems and CRYOPDP will be able to provide market leading support to the most complex and highest value life sciences product supply chains. In conjunction with Cryoport Systems' Cryoportal® Logistics Management Platform, CRYOPDP's complementing UnITy ITSM platform will create an integrated global logistics solution that guarantees customers full visibility, control and integrity of the "chain of custody" and "chain of condition" providing end-to-end operational excellence across all temperature ranges worldwide. This unified global capability falls into Cryoport's Chain of Compliance®, which is an important part of Cryoport's continuous efforts dedicated to de-risking the entirety of the life sciences supply chain processes for its clients.

Jerrell Shelton, Chief Executive Officer of Cryoport, said, "Our acquisition of CRYOPDP is an important milestone in carrying out Cryoport's strategy to further entrench and strengthen our global footprint and support capabilities for the entire life sciences industry and especially for the fastest growing segment of high value, lifesaving cell and gene therapies. CRYOPDP is made up of a strong team of professionals and led by experienced and highly motivated leadership. CRYOPDP is especially strong in EMEA and APAC, where it enjoys a strong reputation as a valued specialist logistics provider to CROs (clinical research organizations), the pharmaceutical industry, and the life sciences clinical research community. Over the coming months we anticipate focusing more attention on the fast-growing cell and gene therapy industry, where CRYOPDP will play an increasing role. CRYOPDP's best-in-class temperature-controlled logistics solutions are complementary to Cryoport Systems' existing offering, which will allow both companies to leverage each other's strengths and expand our high growth profile as well as provide a broader array of temperature-controlled supply chain solutions to our respective client bases through coordinated cross-selling and up-selling of our new unified capabilities."

"Life science industry participants, including clients of Cryoport Systems and CRYOPDP, regularly provide feedback about operational "pain points" and areas in which they would like to see Cryoport develop in order to provide end-to-end supply chain support of their clinical and commercial portfolios. The addition of CRYOPDP is a move that we believe addresses this feedback. Together with our organic growth initiatives to build our robust software infrastructure and the most advanced temperature-controlled global supply chain network, this addition of CRYOPDP will enable us to further extend our capabilities into the full range of temperature-controlled supply chain solutions for the life sciences, as well as immediately expand our global infrastructure. The number of cellular and gene therapy trials is growing and with an increasing number of commercial therapies coming to market, this acquisition proactively strengthens our ability to meet the growing global demands of our life sciences clients, in research, clinical and commercial settings. We are looking forward to closing this transaction and officially welcoming the CRYOPDP team to Cryoport, Inc.," concluded Mr. Shelton.

Share:

 

Email Print

 

More Grand Rounds:

 

Tennessee Department Of Health Joins New Cdc Suicide Prevention Program

Tennessee One of Nine Programs Funded for Suicide Prevention

Read More

AdhereHealthUnveils Newest Adhere™ Platform SaaS Offering for Medicare Advantage Plans toMaximize Star Ratings Performance

Adhere Platform's Resolve™ cloud-based software solution enables clinicians to engage with health plan consumers and their providers through intelligent clinical workflow

Read More

AHIP Launches Season 3 of

AHIP Launches Season 3 of "The Next Big Thing in Health" Podcast Featuring Top Innovators in Health Care

AHIP launched season 3 of its award-winning podcast, "The Next Big Thing in Health." The podcast, hosted by Matt Eyles, AHIP president & CEO, and Laura Evans, former FOX 5 DC anchor, features in-depth conversations that highlight the insights, growing trends, and perspectives from health care innovators who are finding new, more effective ways to deliver better value and better care for patients.

Read More

TriStar Skyline Medical Center Celebrates 20th Anniversary

TriStar Skyline Medical Center Celebrates 20th Anniversary

This week, we celebrate the 20th Anniversary of TriStar Skyline Medical Center. We would have preferred to celebrate this milestone with a community celebration, but COVID-19 has halted our event plans.

Read More

OGA Breaks Ground on new Murfreesboro Medical Facility    Outpatient facility to be developed in partnership with United Surgical Partners Internation

OGA Breaks Ground on new Murfreesboro Medical Facility Outpatient facility to be developed in partnership with United Surgical Partners Internation

Outpatient facility to be developed in partnership with United Surgical Partners International

Read More

Flagship Healthcare Properties Hires Blake Bratcher as Executive Vice President

Read More

AMA Awards Research Grants to Advance the Study of Women in Medicine

Each September, the American Medical Association (AMA) recognizes influential female physician leaders as part of Women in Medicine Month.

Read More

Bridge Connector Raises $25.5 Million in Series B Funding to Advance Interoperability Layer for Health Care

Integration provider closes round as demand for integrated health data intensifies during COVID-19 pandemic

Read More

axialHealthcare Partners with Shatterproof to End Substance Use Disorder Stigma

Read More

Adventist Health and Synchronous Health Announce Strategic Partnership

Partnership leverages power of human touch with AI to deliver behavioral healthcare to millions of people; Includes investment in Synchronous Health

Read More

Change Healthcare Acquires Nucleus.io

Creates first of its kind end-to-end, cloud-native Enterprise Imaging platform

Read More

Ascension Saint Thomas Rutherford Partners with Rutherford County to Deliver On-Site, Near-Site Clinic Care

Ascension Saint Thomas Rutherford Partners with Rutherford County to Deliver On-Site, Near-Site Clinic Care

On September 1, Ascension Saint Thomas will officially partner with Rutherford County to provide on-site and near-site clinic services at three sites of care for Rutherford County employees, the employees' dependents and County retirees.

Read More

Gibbs joined Nashville General Hospital as Chief Marketing Officer

Gibbs joined Nashville General Hospital as Chief Marketing Officer

Sherry D. Gibbs, MBA, joined Nashville General Hospital in the newly created role of Chief Marketing Officer on June 15, 2020. She will be responsible for leading strategic marketing, corporate communications and brand management.

Read More

ObjectiveGI Partnering with ARcare to Provide Advanced Diagnostics and Cutting-Edge Treatment Options for Patients

The clinically integrated research platform will provide thousands of patients with chronic digestive health conditions in the ARcare network access to advanced care options.

Read More

Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

Acquisition will expand Cryoport's presence in both the EMEA and APAC regions and broaden Cryoport's range of temperature-controlled supply chain solutions for the life sciences; Upon closing, the acquisition is expected to be immediately accretive to earnings.

Read More

Klara Raises $15M from Google's AI-Fund Gradient Ventures and Leading Healthcare Investor Frist Cressey to Enable Medical Teams to Offer High Quality

New York City-based digital health company Klara, the leader in patient engagement solutions, today announced it had raised $15 million, co-led by Google's AI-focused venture fund Gradient Ventures and leading healthcare investor Frist Cressey Ventures.

Read More

Delta Dental of Tennessee Donates $325,000 to Children's Hospitals

Delta Dental of Tennessee Donates $325,000 to Children's Hospitals

Support comes at a critical time for children's hospitals facing steep revenue and fundraising drops during COVID-19 pandemic

Read More

Mayor Cooper Visit, Back To School Giveaways And More For National Health Center Week!

Mayor Cooper Visit, Back To School Giveaways And More For National Health Center Week!

National Health Center Week is a wrap! We had a fantastic time celebrating our staff and the community throughout the week, and we couldn't have done it without you!

Read More

BlueCross Medicare Advantage Quality Program Acknowledges Primary Care Physicians for Superior Patient Care Outcomes

Area doctors celebrated for cost-effective, quality care

Read More

Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today provided a company update and announced second quarter 2020 financial results.

Read More

 
 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: